BG Medicine Lowers Expected IPO Share Price to $7 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BG Medicine today lowered the expected share price for its proposed initial public offering to $7, the second time it has lowered its price since filing for the IPO a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.